162 related articles for article (PubMed ID: 8821738)
1. When is the maximal effect of pre-administered systemic morphine on carrageenin evoked spinal c-Fos expression in the rat?
Honoré P; Chapman V; Buritova J; Besson JM
Brain Res; 1995 Dec; 705(1-2):91-6. PubMed ID: 8821738
[TBL] [Abstract][Full Text] [Related]
2. Intraplantar morphine depresses spinal c-Fos expression induced by carrageenin inflammation but not by noxious heat.
Honoré P; Buritova J; Besson JM
Br J Pharmacol; 1996 Jun; 118(3):671-80. PubMed ID: 8762093
[TBL] [Abstract][Full Text] [Related]
3. The contribution of NMDA receptor activation to spinal c-Fos expression in a model of inflammatory pain.
Chapman V; Honoré P; Buritova J; Besson JM
Br J Pharmacol; 1995 Sep; 116(1):1628-34. PubMed ID: 8564229
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-Fos expression in the spinal cord of the rat.
Chapman V; Honoré P; Buritova J; Besson JM
Neuroscience; 1995 Aug; 67(3):731-9. PubMed ID: 7675199
[TBL] [Abstract][Full Text] [Related]
5. Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin.
Honoré P; Buritova J; Besson JM
Eur J Pharmacol; 1995 Jan; 272(2-3):249-59. PubMed ID: 7713169
[TBL] [Abstract][Full Text] [Related]
6. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048
[TBL] [Abstract][Full Text] [Related]
7. Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor.
Honoré P; Chapman V; Buritova J; Besson JM
Br J Pharmacol; 1995 Jan; 114(1):77-84. PubMed ID: 7536097
[TBL] [Abstract][Full Text] [Related]
8. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
Honoré P; Chapman V; Buritova J; Besson JM
J Pharmacol Exp Ther; 1996 Jul; 278(1):393-403. PubMed ID: 8764375
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with systemic morphine induced tolerance to the systemic and peripheral antinociceptive effects of morphine on both carrageenin induced mechanical hyperalgesia and spinal c-Fos expression in awake rats.
Honoré P; Catheline G; Le Guen S; Besson JM
Pain; 1997 May; 71(1):99-108. PubMed ID: 9200179
[TBL] [Abstract][Full Text] [Related]
10. Development of tolerance to the antinociceptive effect of systemic morphine at the lumbar spinal cord level: a c-Fos study in the rat.
Le Guen S; Catheline G; Besson JM
Brain Res; 1998 Nov; 813(1):128-38. PubMed ID: 9824685
[TBL] [Abstract][Full Text] [Related]
11. Concurrent reduction of inflammation and spinal Fos-LI neurons by systemic diclofenac in the rat.
Buritova J; Honoré P; Chapman V; Besson JM
Neurosci Lett; 1995 Mar; 188(3):175-8. PubMed ID: 7609902
[TBL] [Abstract][Full Text] [Related]
12. Spatial and temporal expression of c-Fos protein in the spinal cord of anesthetized rat induced by subcutaneous bee venom injection.
Luo C; Chen J; Li HL; Li JS
Brain Res; 1998 Sep; 806(2):175-85. PubMed ID: 9739136
[TBL] [Abstract][Full Text] [Related]
13. RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal level.
Le Guen S; Noble F; Fournié-Zaluski MC; Roques BP; Besson JM; Buritova J
Eur J Pharmacol; 2002 Apr; 441(3):141-50. PubMed ID: 12063085
[TBL] [Abstract][Full Text] [Related]
14. Peripheral and/or central effects of racemic-, S(+)- and R(-)-flurbiprofen on inflammatory nociceptive processes: a c-Fos protein study in the rat spinal cord.
Buritova J; Besson JM
Br J Pharmacol; 1998 Sep; 125(1):87-101. PubMed ID: 9776348
[TBL] [Abstract][Full Text] [Related]
15. Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat.
Le Guen S; Catheline G; Besson JM
Eur J Pharmacol; 1999 May; 373(1):1-11. PubMed ID: 10408246
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S). A spinal c-Fos protein study in the rat under carrageenin inflammation.
Le Guen S; Catheline G; Fournié-Zaluski MC; Roques BP; Besson JM; Buritova J
Brain Res; 2003 Mar; 967(1-2):106-12. PubMed ID: 12650971
[TBL] [Abstract][Full Text] [Related]
17. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
Chapman V; Buritova J; Honoré P; Besson JM
J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
[TBL] [Abstract][Full Text] [Related]
18. The contribution of GABAB receptor-mediated events to inflammatory pain processing: carrageenan oedema and associated spinal c-Fos expression in the rat.
Buritova J; Chapman V; Honoré P; Besson JM
Neuroscience; 1996 Jul; 73(2):487-96. PubMed ID: 8783264
[TBL] [Abstract][Full Text] [Related]
19. Fos-like immunoreactivity induced by intraplantar injection of endotoxin and its reduction by morphine.
Saadé NE; Abou Jaoude PG; Saadeh FA; Hamoui S; Safieh-Garabedian B; Kanaan SA; Atweh SF; Jabbur SJ
Brain Res; 1997 Sep; 769(1):57-65. PubMed ID: 9374273
[TBL] [Abstract][Full Text] [Related]
20. The effects of morphine on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist.
Honoré P; Buritova J; Besson JM
Brain Res; 1996 Sep; 732(1-2):242-6. PubMed ID: 8891291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]